In melanoma, aberrant expression of a gene leads to the upregulation of immune checkpoint molecules, which inhibits the activation and killing function of CD8+ T cells and promotes the immune escape of tumor cells (Sade-Feldman et al., 2017). This evidence concerns the gene CD8A and neoplasm.